News broke on Tuesday morning that the company has accepted a buyout offer from Hologic Cynosure has agreed to be purchased for $1.65 billion, or$66 per share. Hologic plans onusing cash to fund the deal, which will cost the company $1.44 billion after netting out Cynosure’s cash balance.The deal has already been given the green light from theboards of directors of both companies.